SCHEMBL4594939

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL29138125	0.89	SLC6A2 (0.39)	—
	SCHEMBL25249532	0.89	SLC6A2 (0.39)	—
	SCHEMBL1863664	0.88	SLC6A4 (0.40)	—
	SCHEMBL2707862	0.88	SLC6A4 (0.40)	—
	SCHEMBL1863662	0.88	SLC6A4 (0.40)	—
	SCHEMBL6125628	0.86	GPR119 (0.34)	GPR119
	SCHEMBL22234221	0.83	SLC6A4 (0.36)	GPR119
	SCHEMBL25105378	0.83	SLC6A4 (0.45)	—
	SCHEMBL25104882	0.83	SLC6A4 (0.45)	—
	SCHEMBL2551374	0.83	SLC6A4 (0.45)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.